Evidence map›Paper›PMID 34211961›Full record

ArticleFrontiers in chemistry2021

Site-Specific N- and O-Glycosylation Analysis of Human Plasma Fibronectin.

Ding Liu, Shuaishuai Wang, Junping Zhang, Weidong Xiao, Carol H Miao, Barbara A Konkle, Xiu-Feng Wan, Lei Li

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Exploration of biomarkers for inhibitor development in persons with hemophilia A.Research and practice in thrombosis and haemostasis · 2025
    Article
  4. Article
  5. UnravelingAnalytical chemistry · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. The glycosylation in SARS-CoV-2 and its receptor ACE2.Signal transduction and targeted therapy · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ding LiuDepartment of Chemistry, Georgia State University, Atlanta, GA, United States.
Shuaishuai WangDepartment of Chemistry, Georgia State University, Atlanta, GA, United States.
Junping ZhangSchool of Medicine, Indiana University, Indianapolis, IN, United States.
Weidong XiaoSchool of Medicine, Indiana University, Indianapolis, IN, United States.
Carol H MiaoCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, United States.
Barbara A KonkleBloodworks Northwest, Seattle, WA, United States.
Xiu-Feng WanCenter for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, MO, United States.
Lei LiDepartment of Chemistry, Georgia State University, Atlanta, GA, United States.

Funding

Temple Project 1: Genetic characterization of factor VIII Inhibitors and glydosylation patternsU54HL142019 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI LI, LEI, MIAO, CAROL H · 2018 to 2022
$6.9M
NHLBI NIH HHS U54 HL142019
6 · The paper itself

Abstract

Human plasma fibronectin is an adhesive protein that plays a crucial role in wound healing. Many studies had indicated that glycans might mediate the expression and functions of fibronectin, yet a comprehensive understanding of its glycosylation is still missing. Here, we performed a comprehensive N- and O-glycosylation mapping of human plasma fibronectin and quantified the occurrence of each glycoform in a site-specific manner. Intact N-glycopeptides were enriched by zwitterionic hydrophilic interaction chromatography, and N-glycosite sites were localized by the

Indexed as

fibronectinglycosylationmass spectrometeroperatorstepped normalized collision energy

Identifiers

PMID34211961
PMCPMC8239226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.